Chronic kidney disease is often described by stage. Although staging is important, two people with the same estimated glomerular filtration rate, or eGFR, may have very different risks of progressing to kidney failure. The Kidney Failure Risk Equation (KFRE) adds an important dimension: it estimates an individual’s probability of requiring dialysis or kidney transplantation within the next two or five years.
By Majd Isreb, MD, FACP, FASN, IFMCP
In an integrative nephrology approach, the KFRE is not the entire assessment—and it does not dictate care by itself. Instead, it provides an evidence-based starting point for understanding the urgency of the situation, communicating risk clearly, and developing a personalized plan that addresses both proven treatments and potentially modifiable contributors to kidney disease progression.
Why CKD stage does not tell the whole story
CKD stage is primarily based on eGFR, with albuminuria used to further classify risk. However, eGFR alone is a snapshot of kidney filtration at one point in time. It does not fully capture how likely a person is to reach kidney failure within a clinically meaningful time frame.
For example, two patients may both have an eGFR of 28 mL/min/1.73 m². One may have minimal albuminuria and stable kidney function over several years. The other may have severe albuminuria and a steadily declining eGFR. Their current CKD stage is the same, but their future risk may be very different.
That distinction matters. It affects how frequently the patient should be monitored, how aggressively reversible contributors should be addressed, and when discussions about transplantation or dialysis should begin.
What is the Kidney Failure Risk Equation?
The most commonly used four-variable KFRE uses:
- Age
- Sex
- eGFR
- Urine albumin-to-creatinine ratio, or UACR
Using these variables, the equation estimates the probability of treated kidney failure—dialysis or kidney transplantation—within two and five years. It was originally developed in people with CKD stages G3–G5 and has subsequently been validated in large, multinational populations.
An eight-variable version also exists and adds serum albumin, calcium, phosphate, and bicarbonate. In everyday practice, however, the four-variable equation is often the most convenient because it relies on information commonly collected during routine CKD care.
What does a KFRE percentage mean?
A KFRE result is an estimate, not a prediction of exactly what will happen to one individual.
For example, a calculated five-year risk of 15% does not mean that the patient will develop kidney failure in five years. It means that among people with similar characteristics, approximately 15 out of 100 would be expected to reach treated kidney failure during that period.
The percentage is most useful when placed in context with:
- The underlying cause of kidney disease
- The direction and rate of change in eGFR
- The severity and trend of albuminuria
- Blood pressure and metabolic control
- Episodes of acute kidney injury
- Cardiovascular disease and other competing health risks
- Frailty, symptoms, life expectancy, and the patient’s goals
How the KFRE can guide the intensity of kidney care
The 2024 Kidney Disease: Improving Global Outcomes guideline recommends using an externally validated kidney failure risk equation in people with CKD G3–G5. It also describes several risk thresholds that may help guide care:
- A five-year kidney failure risk of 3%–5% may help determine the need for nephrology referral, in addition to criteria based on eGFR, albuminuria, and other clinical findings.
- A two-year risk above 10% may help determine when multidisciplinary CKD care is appropriate.
- A two-year risk above 40% may help guide education about kidney-replacement options and preparation for transplantation or dialysis access.
These are decision-support thresholds, not automatic rules. A patient may require nephrology care even with a low calculated risk because of rapid eGFR decline, persistent hematuria, nephrotic syndrome, resistant hypertension, electrolyte abnormalities, suspected genetic disease, or uncertainty about the diagnosis.
Where does the KFRE fit within integrative nephrology?
The KFRE helps answer one important question:
How likely is this patient to require dialysis or kidney transplantation within the next two or five years?
An integrative assessment asks the next question:
What is driving this patient’s kidney disease, and which factors can we safely and meaningfully address?
At the Integrative Kidney Institute, this broader evaluation can be organized around six interconnected areas.
1. Genetics and epigenetics
The first step is confirming that the diagnosis is correct. A risk percentage cannot identify the cause of kidney disease. In selected patients, family history, age at presentation, kidney imaging, hearing or eye findings, persistent hematuria, cystic disease, or an unexplained biopsy pattern may point toward a hereditary disorder.
Identifying a genetic cause can alter treatment, prognosis, family screening, transplant counseling, and the avoidance of unnecessary immunosuppression.
2. Nutrition
Nutrition should be individualized rather than reduced to a universal list of prohibited foods. The appropriate plan may involve sodium reduction, adjustment of protein quantity and quality, greater intake of minimally processed plant foods, adequate fiber and calories, or individualized management of potassium and phosphorus.
The plan must also protect against protein-energy wasting, loss of muscle, and overly restrictive eating—especially in older adults or those with advanced CKD.
3. Lifestyle
Blood-pressure measurement, physical activity, sleep, smoking, weight, medication adherence, and management of stress all deserve attention. These interventions should support, rather than replace, established kidney-protective treatment.
A higher KFRE result may make the need for sustained lifestyle changes more tangible, while a lower result may reassure the patient without creating false confidence.
4. Environmental and medication exposures
An integrative history should look for repeated or ongoing kidney stressors. Depending on the individual, these may include nonsteroidal anti-inflammatory drugs, unregulated supplements, certain herbal products, occupational exposures, heavy metals, recurrent dehydration, or repeated episodes of acute kidney injury.
The goal is not to blame every exposure for CKD. It is to identify plausible, preventable contributors while avoiding unsupported testing or detoxification treatments.
5. Gut health and the microbiome
The gut–kidney connection is an important and evolving area of research. Constipation, low fiber intake, gastrointestinal disease, dietary patterns, and repeated antibiotic exposure may all be relevant to the overall assessment.
However, mechanistic promise is not the same as proven clinical benefit. Microbiome-directed diets, prebiotics, probiotics, or other therapies should be presented with appropriate caution and should not displace treatments already shown to reduce kidney and cardiovascular events.
6. Pharmaceuticals and evidence-based kidney protection
An integrative approach includes appropriate conventional treatment. Depending on the patient’s diagnosis and clinical circumstances, the plan may include:
- Renin–angiotensin system blockade
- An SGLT2 inhibitor
- Finerenone for eligible patients with type 2 diabetes and CKD
- GLP-1–based therapy when clinically indicated
- Individualized blood-pressure and glycemic management
- Lipid-lowering therapy and cardiovascular risk reduction
- Treatment of metabolic acidosis and other CKD complications when appropriate
Integrative care should make evidence-based treatment more personalized and comprehensive—not create a false choice between medication and lifestyle.
Turning a risk estimate into an action plan
For someone with a low two-year risk but a meaningful five-year risk, the priorities may include clarifying the diagnosis, optimizing kidney-protective therapy, addressing nutrition and lifestyle, reducing cardiovascular risk, avoiding nephrotoxins, and monitoring the trajectory over time.
For someone with a high two-year risk, those measures remain essential, but they should occur alongside timely preparation for possible kidney failure. That may include:
- Early transplant referral and discussion of living donation
- Education about home and in-center dialysis options
- Preservation of suitable arm veins
- Planning for dialysis access or a peritoneal dialysis catheter when appropriate
- Treatment of anemia, metabolic acidosis, potassium disorders, CKD-mineral and bone disorder, malnutrition, and symptoms
- Discussion of conservative kidney management when it is consistent with the patient’s circumstances and goals
Integrative interventions should never delay transplant evaluation, dialysis education, or access planning when the predicted risk and clinical course indicate that these steps are needed.
Following risk over time
The KFRE can be recalculated when updated eGFR and UACR results become available. Its greatest value may come from viewing it alongside the patient’s broader trajectory:
- eGFR slope
- UACR trend
- Home and office blood pressure
- Glycemic control
- Changes in medications
- Nutritional status and body composition
- Acute kidney injury episodes or hospitalizations
A falling risk estimate accompanied by stable kidney function and sustained improvement in albuminuria can be encouraging. However, a change in KFRE does not prove that one particular food, supplement, medication, or lifestyle intervention caused the improvement. Both eGFR and UACR can fluctuate, and some kidney-protective medications may cause an expected early change in eGFR before providing longer-term benefit.
What the KFRE cannot tell us
The equation has important limitations:
- It estimates treated kidney failure, not the risks of cardiovascular events, hospitalization, acute kidney injury, symptoms, or death.
- It was developed primarily for people with CKD G3–G5 and should not be casually extrapolated to every patient with kidney disease.
- It should not be calculated during an episode of acute kidney injury or from laboratory values that do not reflect the patient’s usual condition.
- It does not include the cause of CKD, eGFR slope, comorbidities, frailty, social circumstances, access to care, or patient preferences.
- Competing mortality risk may affect its interpretation, particularly in older adults and people with serious comorbid illness.
- A low score does not exclude a serious kidney disorder requiring investigation or treatment.
The KFRE is therefore best viewed as one validated tool within a complete clinical evaluation.
Calculate your kidney failure risk
If you have CKD stage 3–5 and recent results for your eGFR and urine albumin-to-creatinine ratio, use the Integrative Kidney Institute’s Kidney Failure Risk Equation Calculator to estimate your two- and five-year risk.
CALCULATE YOUR KIDNEY FAILURE RISK
The result can provide a more useful starting point for a conversation with your kidney-care team:
- What is causing my kidney disease?
- Is my kidney function stable or declining?
- Which proven treatments are appropriate for me?
- Which nutritional, lifestyle, environmental, or medication factors should we address?
- How often should my kidney function and albuminuria be checked?
- Is it time to discuss transplantation or dialysis planning?
CKD stage tells us where kidney function is today. The Kidney Failure Risk Equation helps estimate where it may be heading. An integrative approach connects that estimate to the whole person—and turns risk information into an individualized, evidence-based plan.
Important note
This calculator and article are provided for education and are not a diagnosis or a substitute for individualized medical care. The result should be interpreted by a qualified healthcare professional familiar with your medical history. Do not change medications, supplements, diet, or kidney-replacement planning based on the calculator alone.
References
- Kidney Disease: Improving Global Outcomes. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105(Suppl 4S):S117–S314. KDIGO guideline.
- Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553–1559. doi:10.1001/jama.2011.451.
- Tangri N, Grams ME, Levey AS, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA. 2016;315(2):164–174. doi:10.1001/jama.2015.18202.
- National Kidney Foundation. Kidney failure and the Kidney Failure Risk Equations: what you need to know. Patient resource.
